Novel Androgen Deprivation Treatment for Advanced Prostate Cancer
Annenberg Center for Health Sciences
- 4
- Episodes
- 2021
- First episode
About Novel Androgen Deprivation Treatment for Advanced Prostate Cancer
Prostate cancer is the most common cancer diagnosed among men in the United States. Considered curable if diagnosed at a localized stage, the survival rate of men with metastatic disease is dramatically reduced. Due to the androgen-dependence of prostate cancer, androgen deprivation therapy (ADT) has been the mainstay and primary therapeutic approach for management of men with metastatic prostate cancer. Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of
- Publisher
- Annenberg Center for Health Sciences
- Category
- health & fitness
- Language
- en
- Explicit
- No
- First episode
- 10 Dec 2021
- Latest episode
- 10 Dec 2021
Latest episodes
4 episodes in the feed.
10 Dec 2021
Patient Preferences
10 Dec 2021
Exploring Optimal Therapeutic Options
10 Dec 2021
Current State of Care in Advanced PCa
10 Dec 2021
Androgen Deprivation Therapy: Clinical Differences
Contact Novel Androgen Deprivation Treatment for Advanced Prostate Cancer
- Guest appearances
- Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Novel Androgen Deprivation Treatment for Advanced Prostate Cancer?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine